ARTL US Equity

Artelo Biosciences, Inc.

Health Care · Pharmaceutical Preparations · CIK 1621221 · FY ends Dec 31

$0.69

-0.02 (-2.86%)

USD · as of 2026-08-21 · marketstack

Switch Ticker

Events

Date	Event	What happened / filer	Source
2026-08-14	13G/A	Schedule 13G amendment — ≥5% beneficial owner (passive) · by ARMISTICE CAPITAL, LLC	sec.gov ↗
2026-08-13	13G/A	Schedule 13G amendment — ≥5% beneficial owner (passive) · by INTRACOASTAL CAPITAL, LLC	sec.gov ↗
2026-07-17	8-K 5.07	Submission of matters to a vote of security holders	sec.gov ↗

Date

Event

What happened / filer

Source

2026-08-14

13G/A

Schedule 13G amendment — ≥5% beneficial owner (passive) · by ARMISTICE CAPITAL, LLC

2026-08-13

13G/A

Schedule 13G amendment — ≥5% beneficial owner (passive) · by INTRACOASTAL CAPITAL, LLC

2026-07-17

8-K 5.07

Submission of matters to a vote of security holders

Source: SEC EDGAR (public domain) · history starts 2026-07-17

Every row is a filed document, checked against its EDGAR index.